Response to COVID-19 vaccination imaged by PD-L1 PET scanning
{{output}}
Background: During a phase 0 clinical trial of an investigational programmed cell death ligand-1 (PD-L1) PET tracer in patients with non-small cell lung cancer (NSCLC), three patients received booster doses of COVID-19 vaccines b... ...
